Inventor · disambiguated record
Elizabeth M. Wilson
Also filed as: WILSON ELIZABETH · WILSON ELIZABETH M
5 granted patents·8 pending applications·72 citations·filing 1988–2022
79Inventor score
Top patents by PatentIndex Score
13 records- 0186US6821767B1Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositionsUNIV NORTH CAROLINA·Filed 2000·Granted Nov 23, 2004·24 cites·9 claims
- 0282US6307030B1Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositionsUNIV NORTH CAROLINA·Filed 1988·Granted Oct 23, 2001·42 cites·3 claims
- 0376US7129078B2DNA encoding androgen receptor fragmentUNIV NORTH CAROLINA·Filed 2004·Granted Oct 31, 2006·6 cites·7 claims
- 0464US2011263001A1Compositions and Methods for Engineering CellsLIFE TECHNOLOGIES CORP·Filed 2009·Application pending·0 cites
- 0558US11793178B2Fumarylacetoacetate hydrolase (FAH)-deficient and immunodeficient rats and uses thereofYECURIS CORP·Filed 2019·Granted Oct 24, 2023·0 cites·14 claims
- 0658US2025009808A1Methods of Producing and Using Human Hepatocytes and Related CompositionsCYTOTHERYX INC·Filed 2022·Application pending·0 cites
- 0754US2013040304A1Compositions and Methods for Engineering CellsLIFE TECHNOLOGIES CORP·Filed 2012·Application pending·0 cites
- 0853US10470445B2Fumarylacetoacetate hydrolase (Fah)-deficient and immunodeficient rats and uses thereofYECURIS CORP·Filed 2016·Granted Nov 12, 2019·0 cites·7 claims
- 0952US2016010113A1Compositions and methods for engineering cellsLIFE TECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
- 1048US2014373187A1Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereofBIAL JOHN R·Filed 2012·Application pending·0 cites
- 1148US2021252115A1Inhibition of catalytic site common to multiple 3 alpha-oxidoreductases for treatment of prostate cancerHEALTH RESEARCH INC·Filed 2021·Application pending·0 cites
- 1247US2010150930A1Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancerUNIV NORTH CAROLINA·Filed 2008·Application pending·0 cites
- 1335US2020179408A1Inhibition of catalytic site common to multiple 3 alpha-oxidoreductases for treatment of prostate cancerHEALTH RESEARCH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elizabeth M. Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →